封面
市場調查報告書
商品編碼
1619075

生物製藥分析測試服務市場規模、佔有率、成長分析、按分子類型、按測試類型、按工作流程、按應用、按最終用戶、按地區 - 行業預測,2024-2031 年

Biopharmaceutical Analytical Testing Services Market Size, Share, Growth Analysis, By Molecule Type (Small Molecule, Large Molecule), By Test Type (Pharmacokinetics), By Workflow, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 249 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年生物製藥分析測試服務的全球市場規模為29億美元,從2023年的33.5億美元成長到2031年的106.9億美元,在預測期內(2024-2031年)預計將以複合年成長率成長。

在生物製藥領域,成功的藥物開發取決於先進分析技術支援的蛋白質和化合物的準確分類。這些技術對於理解生物製藥的結構和功能至關重要,為從候選藥物選擇到製程最佳化的每個步驟提供資訊。為了因應不斷發展的研究和開發環境,對多樣化分析工具的需求正在迅速增加。儘管北美的分析測試服務最初因 COVID-19 大流行而關閉和中斷,但限制正在逐漸取消,實驗室運作正在恢復。隨著生命科學服務的恢復,生物製藥分析測試服務的需求預計將增加,從而推動該地區在預測期內的市場成長。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特分析與影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2023)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 監管環境
  • 專利分析

按分子類型和複合年成長率分類的生物製藥分析測試服務市場規模(2024-2031)

  • 市場概況
  • 小分子
  • 高分子

生物製藥分析測試服務市場規模:依測試類型和複合年成長率(2024-2031)

  • 市場概況
  • ADME(吸收分佈代謝排泄)
  • 藥物動力學(PK)
  • 動態(PD)
  • 生物有效性
  • 生物等效性
  • 其他

生物製藥分析測試服務市場規模:依工作流程及複合年成長率(2024-2031)

  • 市場概況
  • 樣品製備
  • 樣品分析

生物製藥分析測試服務市場規模:按應用和複合年成長率(2024-2031)

  • 市場概況
  • 腫瘤學
  • 神經病學
  • 心臟病學
  • 感染疾病
  • 其他

按最終用戶分類的生物製藥分析測試服務市場規模和複合年成長率(2024-2031)

  • 市場概況
  • 製藥和生物技術公司
  • 合約研究組織(CRO)
  • 學術研究所
  • 其他

生物製藥分析測試服務市場規模及複合年成長率(2024-2031)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Eurofins Scientific
  • Charles River Laboratories
  • WuXi AppTec
  • SGS SA
  • Laboratory Corporation of America Holdings(LabCorp)
  • IQVIA
  • Medpace
  • Intertek Group
  • Syneos Health
  • ICON plc
  • Frontage Laboratories
  • PPD(Pharmaceutical Product Development)
  • PAREXEL International
  • Almac Group
  • Celerion
  • Altasciences
  • BioAgilytix Labs
  • Lotus Labs
  • LGS Limited
  • Sartorius AG

結論和建議

簡介目錄
Product Code: SQMIG35H2168

Global Biopharmaceutical Analytical Testing Services Market size was valued at USD 2.90 billion in 2022 and is poised to grow from USD 3.35 billion in 2023 to USD 10.69 billion by 2031, growing at a CAGR of 15.6% during the forecast period (2024-2031).

In the biopharmaceutical sector, successful drug development hinges on the precise classification of proteins and compounds, supported by advanced analytical methods. These technologies are essential for comprehending the structure and functionality of biotherapeutics, informing every stage from drug candidate selection to process optimization. The demand for diverse analytical tools is surging in response to the evolving R&D landscape. Although the COVID-19 pandemic initially hindered analytical testing services in North America due to lockdowns, the gradual lifting of restrictions has rejuvenated laboratory operations. As life sciences services resume, there is an anticipated increase in demand for biopharmaceutical analytical testing services, propelling market growth in the region throughout the forecasted period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceutical Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceutical Analytical Testing Services Market Segmental Analysis

Global Biopharmaceutical Analytical Testing Services Market is segmented by molecule type, test type, workflow, application, end user and region. Based on molecule type, the market is segmented into small molecule and large molecule. Based on test type, the market is segmented into ADME (absorption, distribution, metabolism, and excretion), pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence and others. Based on workflow, the market is segmented into sample preparation and sample analysis. Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases and others. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceutical Analytical Testing Services Market

A significant driver of growth in the global biopharmaceutical analytical testing services market is the escalating demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene, primarily used in immunotherapy to enhance immune responses against various diseases. Research and development initiatives focused on antibodies for conditions such as rheumatoid arthritis and cancer are expanding. Targeted treatments for cancer involve specific localization to improve efficacy. Additionally, the rising preference for customized medicine is boosting the need for monoclonal antibodies, prompting pharmaceutical and biotechnology companies to manufacture Ethyl Methacrylate Acrylonitrile. Consequently, these products undergo rigorous quality control processes, including microbial, sterility, and dissolution testing, to ensure drug integrity, which subsequently fuels the demand for biopharmaceutical analytical testing services that provide critical impurity data, characterization, and validation.

Restraints in the Global Biopharmaceutical Analytical Testing Services Market

Global Biopharmaceutical Analytical Testing Services face several restraints that can impact their operations and growth. Stringent regulatory requirements necessitate rigorous compliance, potentially delaying product testing and market entry. The rapidly evolving technological landscape demands continuous investment in advanced analytical methods, which can strain financial resources. Additionally, the shortage of skilled professionals in the biopharmaceutical field can hinder the capacity to meet increasing demand for testing services. Competition among service providers leads to price pressures, while the complexity of biologics requires specialized expertise that may not be universally available, limiting the ability to scale operations efficiently within a global framework.

Market Trends of the Global Biopharmaceutical Analytical Testing Services Market

The Global Biopharmaceutical Analytical Testing Services market is witnessing a significant upward trend, fueled by heightened investments in research and development (R&D). With R&D expenditures surging by 3.21% in 2021, the focus on enhancing analytical testing capabilities is set to intensify. Emerging economies are outpacing their developed counterparts, showcasing robust growth through the establishment of new laboratories and research facilities. This shift not only fosters innovation but also enhances the overall capacity for biopharmaceutical testing, meeting the increasing demand for high-quality and efficient biotherapeutic solutions. As a result, the market is poised for substantial expansion in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Patent Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Molecule Type & CAGR (2024-2031)

  • Market Overview
  • Small Molecule
  • Large Molecule

Global Biopharmaceutical Analytical Testing Services Market Size by Test Type & CAGR (2024-2031)

  • Market Overview
  • ADME (Absorption, Distribution, Metabolism, and Excretion)
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Bioavailability
  • Bioequivalence
  • Others

Global Biopharmaceutical Analytical Testing Services Market Size by Workflow & CAGR (2024-2031)

  • Market Overview
  • Sample Preparation
  • Sample Analysis

Global Biopharmaceutical Analytical Testing Services Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Others

Global Biopharmaceutical Analytical Testing Services Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others

Global Biopharmaceutical Analytical Testing Services Market Size & CAGR (2024-2031)

  • North America (Molecule Type, Test Type, Workflow, Application, End User)
    • US
    • Canada
  • Europe (Molecule Type, Test Type, Workflow, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Molecule Type, Test Type, Workflow, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Molecule Type, Test Type, Workflow, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Molecule Type, Test Type, Workflow, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings (LabCorp)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IQVIA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medpace
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intertek Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syneos Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Frontage Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PPD (Pharmaceutical Product Development)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PAREXEL International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Almac Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celerion
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Altasciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioAgilytix Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lotus Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LGS Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation